Charles Anthony Taylor, Jr

Menlo Park, CA, United States of America

Charles Anthony Taylor, Jr

Average Co-Inventor Count = 2.0

ph-index = 51

Forward Citations = 7,667(Granted Patents)

Forward Citations (Not Self Cited) = 5,333(Sep 21, 2024)

DiyaCoin DiyaCoin 19.13 

Inventors with similar research interests:


Location History:

  • Palo Alto, CA (US) (2001)
  • Irvine, CA (US) (2011)
  • Menlo Park, MD (US) (2016)
  • Johnson City, TX (US) (2016)
  • San Mateo, CA (US) (2013 - 2020)
  • Torrance, CA (US) (2023)
  • Menlo Park, CA (US) (2012 - 2024)
  • Atherton, CA (US) (2018 - 2024)
  • Redwood City, CA (US) (2021 - 2024)


Years Active: 2001-2025

where 'Filed Patents' based on already Granted Patents

200 patents (USPTO):
3 patents (CIPO):

Title: Charles Anthony Taylor, Jr. - Revolutionizing Medical Imaging with Cutting-Edge Patents

Introduction:

In the field of medical imaging, innovation plays a crucial role in improving diagnosis accuracy and patient outcomes. Charles Anthony Taylor, Jr., an accomplished inventor based in Menlo Park, CA, has made significant contributions to the industry with his pioneering patents. With a remarkable 132 patents to his name, Taylor has consistently pushed the boundaries of medical imaging technology. This article explores some of his latest patents, career highlights, notable collaborations, and their implications for the field.

Latest Patents:

1. Systems and methods for embolism prediction using embolus source and destination probabilities:

This patent presents a groundbreaking method for patient risk assessment and treatment planning based on emboli dislodgement and destination probabilities. By utilizing patient-specific imaging and innovative computing processors, Taylor's invention enables the calculation of blood flow characteristics and the determination of embolus destination probability. This breakthrough has the potential to enhance the accuracy and efficacy of embolism prediction, leading to improved patient care.

2. Systems and methods for an interactive tool for determining and visualizing a functional relationship between a vascular network and perfused tissue:

Taylor's second patent introduces an interactive tool that facilitates the analysis and display of the functional relationship between a patient's vascular network and the associated perfused tissue. By integrating patient-specific vascular and tissue models, this invention allows healthcare professionals to visualize and understand the intricate connections between the vasculature and perfusion. This advancement holds great promise for refining treatment planning and enhancing surgical outcomes.

Career Highlights:

Throughout his career, Charles Anthony Taylor, Jr. has excelled in both academic and industry settings. Notably, he has made significant contributions during his tenure with HeartFlow, Inc. This company, renowned for its expertise in cardiovascular diagnostics, has benefited greatly from Taylor's proficiency in medical imaging technology. Furthermore, Taylor has collaborated closely with the esteemed Leland Stanford Junior University, furthering his reputation as a leading figure in the field.

Collaborations:

Taylor's work has not been accomplished in isolation. He has had the privilege of collaborating with exceptional individuals who share his passion for innovation. Notably, he has worked alongside Leo John Grady and Gilwoo Choi, both accomplished professionals in their respective fields. These collaborations have fostered an environment of knowledge exchange and pushed the boundaries of medical imaging advancements.

Conclusion:

Charles Anthony Taylor, Jr. is a pioneering inventor in the field of medical imaging. With a remarkable portfolio of patents, including his latest groundbreaking inventions, he has made significant contributions to the advancement of accurate and real-time medical imaging technology. By pushing the boundaries of what is possible, Taylor has the potential to positively impact patient care and drive innovation in medical imaging. As the field continues to evolve, we eagerly anticipate Taylor's future contributions and their implications for the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…